1-Bromo-4-(diethoxymethyl)benzene

Catalog No.: 
ACDPHN827
CAS No.: 
34421-94-8
Molecular Formula: 
C11H15BrO2
Molecular Weight: 
259.14
1-Bromo-4-(diethoxymethyl)benzene structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100g97%$79.00In stockInquiry
500g97%$273.00In stockInquiry
1000g97%$491.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-Bromo-4-(diethoxymethyl)benzene
IUPAC Name1-bromo-4-(diethoxymethyl)benzene
MDL No.MFCD01863514
Molecular FormulaC11H15BrO2
Molecular Weight259.14
SMILESCCOC(OCC)C1=CC=C(Br)C=C1
InChI KeyBFSNEBVTOODGHZ-UHFFFAOYSA-N
SynonymCS-W010156 | 4-Bromobenzaldehyde diethyl acetal | AMY7729 | BFSNEBVTOODGHZ-UHFFFAOYSA-N | MFCD01863514 | 4-bromobenzaldehydediethyl acetal | 4-BromobenzaldehydeDiethylAcetal | 4-Bromobenzaldehyde diethyl acetal, 99% | CS-17336 | D77705 | AKOS005207008 | B
CAS No.34421-94-8
PubChem CID688340

Synthetic Route by SureRoute

1. ACDPHN827 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDPHN827 route product structure diagram
    ACDPHN82734421-94-8 In Stock
Inquiry

2. ACDPHN827 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDPHN827 route product structure diagram
    ACDPHN82734421-94-8 In Stock
Inquiry

3. ACDPHN827 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDPHN827 route product structure diagram
    ACDPHN82734421-94-8 In Stock
Inquiry

Comments (0)